Used as a key intermediate in the synthesis of pharmaceutical agents targeting central nervous system disorders. Its structure supports the development of compounds with activity against neurodegenerative diseases and psychiatric conditions. Commonly employed in medicinal chemistry for constructing pyridopyridazine-based scaffolds that enhance binding affinity to specific neuronal receptors. Also utilized in research settings to design inhibitors affecting neurotransmitter regulation. Its ester functionality allows for easy modification, enabling rapid generation of derivative compounds for structure-activity relationship studies.